The U.S. Food and Drug Administration (FDA) approved a new generic version of the abortion pill on Tuesday, prompting outrage from conservatives and the pro-life movement.

The FDA’s approval of a generic form of mifepristone — the first drug used in a two-drug medication abortion regimen — comes as the agency, under the direction of the Department of Health and Human Services (HHS), is performing a safety review of the drug following a shocking study suggesting a much higher complication rate than previously reported.

The FDA specifically approved a generic form of the abortion pill produced by Evita Solutions LLC, a company that says its mission is to “normalize abortion” and make it “accessible to all.” In the FDA’s letter to Evita Solutions LLC, the agency said it concluded t

See Full Page